Leptin: A novel target for reducing the risk of heart disease in obesity

Sherma Zibadi, Ronald Ross Watson

Research output: Contribution to specialist publicationArticle

Abstract

These studies lead us to the conclusion that leptin initiates or attenuates the adverse heart remodeling associated with obesity and other hyperleptinemic conditions, which may in turn contribute to the clinical syndrome of heart failure. This will likely provide the basis for future development of leptin-moduiator therapeutics to prevent or lessen adverse cardiac remodeling and dysfunction in obese populations.

Original languageEnglish (US)
Pages735-736
Number of pages2
Volume20
No11
Specialist publicationINFORM - International News on Fats, Oils and Related Materials
StatePublished - Nov 1 2009

    Fingerprint

ASJC Scopus subject areas

  • Biotechnology
  • Food Science
  • Chemistry(all)

Cite this